Actively Recruiting
Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery
Led by Cumhuriyet University · Updated on 2026-02-17
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim is to compare the incidence of postoperative delirium following coronary artery bypass grafting (CABG) between patients receiving dexmedetomidine and those receiving midazolam infusions.
CONDITIONS
Official Title
Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients scheduled for elective coronary artery bypass graft surgery.
You will not qualify if you...
- Patients with renal disorders
- Patients with hepatic disorders
- Patients with neuropsychiatric disorders
- Patients whom informed consent could not be obtained
- Patients who declined to participate in the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye), 58140
Actively Recruiting
Research Team
O
Oğuz Gündoğdu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here